Comprehensive Genomics

Home | Research Accomplishments | Services & Requests | Equipment



The primary mission of the CGSR is to provide a wide range of cost efficient sequencing services to support Rutgers Cancer Institute's precision medicine initiatives and genomics based applications as well as innovative services that are not readily available to cancer researchers. The CGSR labs are located in Newark and offer exciting, cutting-edge services, namely single primer enrichment and long-read sequencing technologies, 10x genomics instruments, and hybrid capture-based panels for targeted DNA and RNA sequencing of clinical tumor and other cancer research tumor samples.

The staff of the CLIA-certified, CAP-accredited Clinical Genomics lab has extensive experience in molecular diagnostics and clinical research, and specializes in clinical biomarker discovery, validation, and diagnostic test development. 


Milind Mahajan, PhD, serves as the Scientific Director of the CGSR and the Newark Genomics Center. He was hired in August 2023 as an Associate Professor of Medicine with the Rutgers New Jersey Medical School bringing extensive experience from the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mt. Sinai and the Depatment of Genetics at Yale University

Veera D’Mello, PhD, serves as the sequencing specialist who was purposed in 2023 to prioritize all Rutgers Cancer Institute sequencing projects.

Alexander Lemenze, PhD, serves as Director of the Molecular and Genomics Informatics Services at Rutgers Cancer Institute. He provides quality control and analysis of sequencing and routes all Rutgers Cancer Institute member projects to the Rutgers Cancer Institute BISR.

Mainul Hoque, PhD, FACMG, is an assistant professor who oversees the performance of all sequencing experiments for the Clinical Genomics Laboratory at Newark.

Situated in New Brunswick Emmanuel Zachariah, PhD, and Curtis Krier continue to coordinate services, perform sample quality control, and consultation for samples to be shipped to Newark for sequencing.



"Services, results, and/or products in support of the research project were generated by the Rutgers Cancer Institute Comprehensive Genomics Shared Resource, supported, in part, with funding from NCI-CCSG P30CA072720-5920."

Please consider including the names of individuals from the shared resource if they provided any intellectual input or additional effort.

NIH Public Access Policy: Publications that result from services provided by this Shared Resource must be compliant with the NIH Public Access policy by submitting your paper to PubMed Central. Go to: for PubMed Central's submission instructions.  

If you require additional guidance on how to properly acknowledge a single shared resource or multiple shared resources, you may contact Janet Bandoy, Shared Resources Coordinator.


Last updated 02/01/2023